Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05053269

Body Weight Growth After Birth and Bronchopulmonary Dysplasia

Association of Body Weight Growth After Birth and Bronchopulmonary Dysplasia(BPD)

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
Sex
All
Age
1 Minute – 1 Day
Healthy volunteers

Summary

Bronchopulmonary dysplasia (BPD) is one of the most common, complex, and severe diseases in preterm infants. BPD was first described as chronic pulmonary disease in survivors of severe respiratory distress syndrome (RDS) in 1967, which was also called as the "old" BPD. In recent years, the definition for BPD has developed a lot. The National Institute of Child Health and Human Development (NICHD) workshop in 2018 assessed BPD at 36 post-menstrual age (PMA) along with radiographic confirmation and used a severity grading of I-III. Although with effective surfactant supplement and oxygen support, BPD brings a great challenge to neonatologists.

Detailed description

Besides persistent inflammation, prolonged invasive ventilation and oxidative damage. body weight is the one of the most important factors to induce BPD. Poor extrauterine growth is commonly described in extremely preterm infants. But, the relationship of postnatal growth with BPD and respiratory morbidity is not entirely understood. The aim of the present study is to assess whether body weight growth after birth is the risk factor for BPD.

Conditions

Interventions

TypeNameDescription
OTHERgood body weight growthbody weight growth after birth is consistent with the growth curve
OTHERpoor body weight growthbody weight growth after birth is inconsistent with the growth curve

Timeline

Start date
2021-10-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2021-09-22
Last updated
2023-05-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05053269. Inclusion in this directory is not an endorsement.